Financiere Des Professionnels Fonds D,Investissement Inc. Krystal Biotech, Inc. Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.66 Trillion
- Q2 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 1,182 shares of KRYS stock, worth $177,477. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,182Holding current value
$177,477% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
332Shares Held
24.2MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$593 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$424 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$410 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$184 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$143 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.85B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...